Sunitha Nagrath Selected Research

Lab-On-A-Chip Devices

1/2020	Microfluidic device for high-throughput affinity-based isolation of extracellular vesicles.
12/2019	New Labyrinth Microfluidic Device Detects Circulating Tumor Cells Expressing Cancer Stem Cell Marker and Circulating Tumor Microemboli in Hepatocellular Carcinoma.
11/2019	Isolation and Profiling of Circulating Tumor-Associated Exosomes Using Extracellular Vesicular Lipid-Protein Binding Affinity Based Microfluidic Device.
1/2017	High-Throughput Microfluidic Labyrinth for the Label-free Isolation of Circulating Tumor Cells.
1/2017	Poor Prognosis Indicated by Venous Circulating Tumor Cell Clusters in Early-Stage Lung Cancers.
12/2014	A radial flow microfluidic device for ultra-high-throughput affinity-based isolation of circulating tumor cells.
11/2014	Cascaded spiral microfluidic device for deterministic and high purity continuous separation of circulating tumor cells.
7/2008	Detection of mutations in EGFR in circulating lung-cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sunitha Nagrath Research Topics

Disease

28	Neoplasms (Cancer) 07/2022 - 12/2007
22	Circulating Neoplastic Cells 07/2022 - 07/2008
8	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2022 - 07/2008
7	Lung Neoplasms (Lung Cancer) 07/2022 - 10/2013
4	Pancreatic Neoplasms (Pancreatic Cancer) 04/2020 - 01/2016
4	Neoplasm Metastasis (Metastasis) 01/2019 - 12/2007
3	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2019
2	Melanoma (Melanoma, Malignant) 01/2021 - 10/2020
2	Prostatic Neoplasms (Prostate Cancer) 01/2019 - 03/2010
1	Residual Neoplasm 07/2022
1	Central Nervous System Diseases (CNS Diseases) 01/2021
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2021
1	Adenocarcinoma 01/2020
1	Hepatocellular Carcinoma (Hepatoma) 12/2019
1	Carcinoma (Carcinomatosis) 01/2019
1	Carcinogenesis 01/2016

Drug/Important Bio-Agent (IBA)

12	Biomarkers (Surrogate Marker)IBA 07/2022 - 12/2007
7	RNA (Ribonucleic Acid)IBA 01/2022 - 03/2010
7	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2017
5	ErbB Receptors (EGF Receptor)IBA 01/2021 - 07/2008
4	graphene oxideIBA 01/2019 - 10/2013
3	Circulating Tumor DNAIBA 07/2022 - 01/2021
3	Immune Checkpoint InhibitorsIBA 03/2021 - 01/2019
3	AntibodiesIBA 11/2020 - 07/2008
3	Pharmaceutical PreparationsIBA 01/2019 - 01/2017
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 07/2008
2	Tyrosine Kinase InhibitorsIBA 03/2021 - 07/2008
2	Membrane Proteins (Integral Membrane Proteins)IBA 11/2020 - 02/2016
1	Circular RNAIBA 07/2022
1	Tumor Biomarkers (Tumor Markers)IBA 01/2022
1	Cell-Free Nucleic AcidsIBA 01/2022
1	Anaplastic Lymphoma KinaseIBA 03/2021
1	Bovine Serum AlbuminIBA 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	CarbonIBA 01/2020
1	NitrogenIBA 01/2020
1	Branched-Chain Amino AcidsIBA 01/2020
1	Lipid Bilayers (Lipid Bilayer)IBA 11/2019
1	LipidsIBA 11/2019
1	PhosphatidylserinesIBA 11/2019
1	Coloring Agents (Dyes)IBA 10/2019
1	Small Cytoplasmic RNAIBA 01/2019
1	Hormones (Hormone)IBA 01/2019
1	Biological ProductsIBA 04/2018
1	Epithelial Cell Adhesion MoleculeIBA 01/2017
1	PolymersIBA 06/2016
1	CytokinesIBA 01/2016
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2016
1	GoldIBA 10/2013
1	Prostate-Specific Antigen (Semenogelase)IBA 03/2010

Therapy/Procedure

12	Therapeutics 07/2022 - 12/2007
8	Lab-On-A-Chip Devices 01/2020 - 07/2008
4	Immunotherapy 07/2022 - 01/2021
4	Precision Medicine 01/2022 - 01/2017
1	Castration 01/2019
1	Radiotherapy 01/2019
1	Perioperative Period 01/2017